miRagen Therapeutics to Present New Interim Data From Phase 1 Clinical Trial of Cobomarsen at the 2018 American Society of Clinical Oncology Annual Meeting

World News: . []

BOULDER Colo May 16 2018 GLOBE NEWSWIRE -- miRagen Therapeutics Inc NASDAQMGEN a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies announced today that new interim data from it s ongoi...

More news and information about Miragen Therapeutics, Inc.

Published By:

Globe Newswire: 22:00 GMT Wednesday 16th May 2018

Published: .

Search for other references to "miragen" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us